Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Coronavirus
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Q&A: Repurposing existing drugs for new uses in cancer — for no profit

  • Meghana Keshavan

By Meghana Keshavan March 9, 2017

Reprints
Off label pills
APStock

Dr. Vikas Sukhatme has plenty of ideas on how to improve cancer therapy.

And they all revolve around repurposing inexpensive, generic drugs that show real scientific promise in extending the lives of cancer patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Inside the fall of star MIT scientist David Sabatini
Inside the fall of star MIT scientist David Sabatini
Pfizer is scolded by a U.K. trade group for…
Pfizer is scolded by a U.K. trade group for remarks its CEO made about vaccination
Pharmalittle: Pfizer is scolded by U.K. industry group over…
Pharmalittle: Pfizer is scolded by U.K. industry group over CEO’s remarks on vaccination; Amgen to lay…
‘A classic case’: A legal expert explains why lawsuits…
‘A classic case’: A legal expert explains why lawsuits challenging abortion pill restrictions may succeed
As it turns 40, the Orphan Drug Act for…
As it turns 40, the Orphan Drug Act for rare diseases needs a refresh
No more ‘playing God’: How the longevity field is…
No more ‘playing God’: How the longevity field is trying to recast its work as serious…

Recommended Stories